Walleye Trading LLC - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 292 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2019. The put-call ratio across all filers is 1.07 and the average weighting 0.3%.

Quarter-by-quarter ownership
Walleye Trading LLC ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2023$272,707
-36.8%
8,912
-26.3%
0.00%
-100.0%
Q2 2023$431,486
-43.2%
12,100
-59.5%
0.00%
-50.0%
Q1 2023$759,460
+6.4%
29,900
+69.9%
0.00%0.0%
Q4 2022$713,856
+105.1%
17,600
+67.6%
0.00%
+100.0%
Q3 2022$348,000
-19.4%
10,500
-14.6%
0.00%0.0%
Q2 2022$432,000
-68.7%
12,290
-59.0%
0.00%
-80.0%
Q1 2022$1,378,000
-28.7%
29,943
+2.7%
0.01%
-16.7%
Q4 2021$1,933,000
+89.9%
29,148
+78.8%
0.01%
+100.0%
Q3 2021$1,018,000
+167.2%
16,300
+254.3%
0.00%
+200.0%
Q2 2021$381,000
-56.2%
4,600
-64.9%
0.00%
-75.0%
Q1 2021$870,000
-51.8%
13,124
-44.2%
0.00%
-50.0%
Q4 2020$1,804,000
+239.7%
23,500
+91.1%
0.01%
+100.0%
Q2 2020$531,000
+40.1%
12,300
-6.7%
0.00%
+100.0%
Q1 2020$379,000
-9.1%
13,189
+100.7%
0.00%
-33.3%
Q4 2019$417,000
+82.9%
6,571
-18.9%
0.00%
+50.0%
Q3 2019$228,000
-50.0%
8,100
-52.9%
0.00%
-50.0%
Q2 2019$456,000
+63.4%
17,200
-23.6%
0.00%
+100.0%
Q4 2018$279,000
-2.8%
22,500
+50.5%
0.00%0.0%
Q3 2018$287,000
+523.9%
14,947
-39.2%
0.00%
Q1 2017$46,00024,6000.00%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q4 2019
NameSharesValueWeighting ↓
ELEMENT CAPITAL MANAGEMENT LLC 142,649$618,0000.25%
ING GROEP NV 808,229$3,500,0000.07%
A.R.T. Advisors, LLC 232,470$1,006,0000.05%
OppenheimerFunds, Inc. 3,000,000$12,990,0000.02%
Edge Wealth Management LLC 10,000$43,0000.01%
First Allied Advisory Services, Inc. 61,000$264,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 200,000$866,0000.01%
MILLENNIUM MANAGEMENT LLC 1,272,138$5,508,0000.01%
D. E. Shaw & Co., Inc. 971,768$4,208,0000.01%
Virtu Financial LLC 18,008$78,0000.00%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders